San Antonio, TX, United States of America

Crystal Rock

This inventor holds 1 USPTO granted patent. Top assignee: USA as Represented by Secretary of the Navy. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Crystal Rock - Innovator in Antifungal Treatments

Introduction

Crystal Rock is an accomplished inventor based in San Antonio, TX (US). He has made significant contributions to the field of medicine, particularly in the treatment of fungal infections. His innovative approach has led to the development of a unique patent that addresses a critical health issue.

Latest Patents

Crystal Rock holds a patent for "Methods of treating fungal infections." This patent describes methods for treating a fungal infection in a subject in need thereof. It involves administering a therapeutically effective amount of a composition that includes one or more antifungal peptides. These peptides are selected from a specific group consisting of BmKn2, dBmKn2, Kn2-7, and dKn2-7. The patent also details antifungal pharmaceutical compositions and dosage forms, including field-deployable dosage forms, that incorporate these antifungal peptides.

Career Highlights

Crystal Rock is currently associated with the USA as Represented by the Secretary of the Navy. His work in this capacity has allowed him to focus on innovative solutions in the medical field, particularly in combating fungal infections. His dedication to research and development has positioned him as a key figure in this area.

Collaborations

Crystal Rock has collaborated with notable coworkers, including Jeremy Wesley Gleaton and Nancy Millenbaugh. These partnerships have fostered a collaborative environment that enhances the development of effective treatments.

Conclusion

Crystal Rock's contributions to antifungal treatments through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to pave the way for advancements in medical treatments for fungal infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…